The incidence of pancreatic adenocarcinoma increases across all age groups, whereas colorectal adenocarcinoma increases only among younger age groups.

From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups, ...

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...

Revolution Medicines, Inc. (NASDAQ:RVMD) on Sunday announced new clinical data for zoldonrasib (RMC-9805), a RAS(ON) ...

A modified FLOT regimen (fluorouracil, oxaliplatin, and docetaxel; TFOX) outperformed a standard chemotherapy triplet for the ...

There has been a sharp increase in colorectal and pancreatic cancer rates among Americans under 55 years, despite declines in ...

BOSTON — Key DNA and chromosomal and immune cell changes in early-stage lung adenocarcinoma show significant associations with outcomes, representing potentially important early predictors to ...

Researchers from Guilin Medical University and collaborators investigated the potential role of ubiquitin-specific protease 4 (USP4) in the occurrence and development of lung adenocarcinoma.

In the US, the incidence of pancreatic cancer is increasing in patients of all ages, and the incidence of colorectal cancer is increasing in patients aged 15-34 years.

Arvind Trindade, MD, discusses the background of a study investigating rates of pancreatic and colon cancer among younger patients.

Between 2000 and 2021, there was an increased incidence of pancreatic adenocarcinoma and a decrease in the incidence of colorectal cancer seen across age groups. HealthDay News — From 2000 to ...